Better Buy: Celgene Corporation vs. Merck [The Motley Fool]
CELGENE (CELG)
Last celgene earnings: 10/31 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.celgene.com
Company Research
Source: The Motley Fool
Which of these oncology leaders will come out ahead? A series of setbacks caused Celgene Corporation ( NASDAQ:CELG ) stock to tumble around 47% from a peak reached last October. Over the same time frame, Merck & Co. ( NYSE:MRK ) shares have slipped a bit even though its lead product hit an important mark that will drive billions in additional annual sales toward the big pharma. Global spending on oncology medicines reached $133 billion in 2017 according to healthcare analytics provider IQVIA, and that figure could reach $200 billion in 2022. Which of these stocks is best poised to ride the trend? Let's look at the case for each to see which drugmaker comes out on top. Image source: Getty Images. The case for Celgene Corporation Celgene's flagship product, Revlimid, made this a top-performing biotech in years past, but the multiple myeloma treatment is going to begin losing market share to generic competition in early 2026. First-quarter sales of the tr
Show less
Read more
Impact Snapshot
Event Time:
CELG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CELG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CELG alerts
High impacting CELGENE news events
Weekly update
A roundup of the hottest topics